North Star Asset Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $426K | Hold |
1,305
| – | – | 0.02% | 242 |
|
|
2025
Q1 | $352K | Sell |
1,305
-5
| -0.4% | -$1.35K | 0.02% | 244 |
|
|
2024
Q4 | $308K | Hold |
1,310
| – | – | 0.01% | 258 |
|
|
2024
Q3 | $360K | Hold |
1,310
| – | – | 0.02% | 243 |
|
|
2024
Q2 | $318K | Sell |
1,310
-200
| -13% | -$48.6K | 0.02% | 254 |
|
|
2024
Q1 | $226K | Sell |
1,510
-5
| -0.3% | -$747 | 0.01% | 289 |
|
|
2023
Q4 | $290K | Hold |
1,515
| – | – | 0.01% | 253 |
|
|
2023
Q3 | $268K | Hold |
1,515
| – | – | 0.02% | 254 |
|
|
2023
Q2 | $288K | Sell |
1,515
-25
| -2% | -$4.75K | 0.02% | 251 |
|
|
2023
Q1 | $308K | Hold |
1,540
| – | – | 0.02% | 248 |
|
|
2022
Q4 | $366K | Hold |
1,540
| – | – | 0.02% | 232 |
|
|
2022
Q3 | $308K | Sell |
1,540
-500
| -25% | -$100K | 0.02% | 232 |
|
|
2022
Q2 | $298K | Buy |
2,040
+20
| +1% | +$2.92K | 0.02% | 237 |
|
|
2022
Q1 | $330K | Hold |
2,020
| – | – | 0.02% | 246 |
|
|
2021
Q4 | $343K | Hold |
2,020
| – | – | 0.02% | 244 |
|
|
2021
Q3 | $381K | Buy |
2,020
+20
| +1% | +$3.77K | 0.02% | 228 |
|
|
2021
Q2 | $339K | Hold |
2,000
| – | – | 0.02% | 238 |
|
|
2021
Q1 | $282K | Hold |
2,000
| – | – | 0.02% | 240 |
|
|
2020
Q4 | $260K | Hold |
2,000
| – | – | 0.02% | 245 |
|
|
2020
Q3 | $291K | Hold |
2,000
| – | – | 0.02% | 218 |
|
|
2020
Q2 | $296K | Sell |
2,000
-1,000
| -33% | -$148K | 0.02% | 213 |
|
|
2020
Q1 | $327K | Hold |
3,000
| – | – | 0.03% | 197 |
|
|
2019
Q4 | $346K | Hold |
3,000
| – | – | 0.02% | 227 |
|
|
2019
Q3 | $241K | Sell |
3,000
-1,000
| -25% | -$80.3K | 0.02% | 250 |
|
|
2019
Q2 | $290K | Hold |
4,000
| – | – | 0.02% | 240 |
|
|
2019
Q1 | $374K | Buy |
+4,000
| New | +$374K | 0.03% | 222 |
|